UPDATE: UBS Securities Upgrades Allergan On Conference Call Takeaways
July 22, 2014 at 09:33 AM EDT
In a report published Tuesday, UBS Securities analyst Marc Goodman upgraded the rating on Allergan (NYSE: AGN) from Neutral to Buy, and ...
